Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Needham Downgrades IronNet to Hold

Needham analyst Mike Cikos downgrades IronNet (NYSE:IRNT) from Buy to Hold.

byBenzinga Newsdesk

December 16, 2021

1 minute read

Needham analyst Mike Cikos downgrades IronNet (NYSE:IRNT) from Buy to Hold.

Tabula Rasa HealthCare Q3 EPS $(0.04) Misses $0.03 Estimate, Sales $86.60M Miss $88.52M Estimate

By Bill Haddad

Today, 10:56 PM

Tabula Rasa HealthCare (NASDAQ:TRHC) reported quarterly losses of $(0.04) per share which missed the analyst consensus estimate of $0.03 by 233.33 percent. This is a 300 percent decrease over losses of $(0.01) per share

TRHC

Analyst Ratings

Where KLA Stands With Analysts

By Benzinga Insights

Today, 10:56 PM

Analysts have provided the following ratings for KLA (NASDAQ:KLAC) within the last quarter:

KLAC

Here’s How Much You Would Have Made Owning Hershey Stock In The Last 5 Years

By Benzinga Insights

Today, 10:56 PM

Hershey (NYSE:HSY) has outperformed the market over the past 5 years by 8.73% on an annualized basis producing…

HSY

SVB Leerink Maintains Outperform on Relmada Therapeutics, Lowers Price Target to $10

By Benzinga Newsdesk

Today, 10:56 PM

SVB Leerink analyst Marc Goodman maintains Relmada Therapeutics (NASDAQ:RLMD) with a Outperform and lowers the price target from $42 to $10.

RLMD

Needham Downgrades IronNet to Hold

Related Posts

Tabula Rasa HealthCare Q3 EPS $(0.04) Misses $0.03 Estimate, Sales $86.60M Miss $88.52M Estimate

Where KLA Stands With Analysts

Here’s How Much You Would Have Made Owning Hershey Stock In The Last 5 Years

SVB Leerink Maintains Outperform on Relmada Therapeutics, Lowers Price Target to $10